Trends in the Utilization of Lipid-Lowering Medications in Australia: An Analysis of National Pharmacy Claims Data.

Current Problems in Cardiology
Stella TalicElla Zomer

Abstract

Lipid-lowering medications comprise standard of care in the prevention of cardiovascular disease. This study examined the trends in the utilization of statin and non-statin medications in the Australian general population between 2013 and 2019. Pharmacoepidemiological analyses were performed using pharmacy dispensing data from Australian Pharmaceutical Benefits Scheme. One-year prevalence and incidence of statin and non-statin prescribing patterns were reported, and relative variations in prescribing examined via Poisson regression modelling. The one-year prevalence of statins' prescriptions decreased between 2013-2019 by 5.5% (from 25.0%-19.5%). Females were less likely than males to be prescribed statins (rate ratio [RR]=0.90, 95% confidence interval [CI] 0.89-0.91). The one-year prevalence of ezetimibe alone, and in combination with statins, increased consistently from 2013-2019 from 1.5%-3.6% (P<0.01) and 0.1%-1.1% (P<0.01), respectively. The prevalence was higher among those aged 61-80 years (RR=1.20, 95%CI 1.10-1.21) and those aged older than 80 years (RR=1.34, 95%CI 1.22-1.47), when compared to people aged <60 years. The incidence of ezetimibe prescriptions was highest in people aged 61-80 years (RR=1.36, 95%CI 1.31-1.41...Continue Reading

References

Oct 20, 2000·BMJ : British Medical Journal·S B HulleyW S Browner
May 6, 2005·Clinical Pharmacokinetics·Teddy KosoglouKevin B Alton
Apr 1, 2008·The New England Journal of Medicine·Cynthia A JackeviciusHarlan M Krumholz
Oct 2, 2008·Vascular Health and Risk Management·Carlos EscobarVivencio Barrios
Jun 30, 2010·Drugs & Aging·Marjolein Geleedst-De VooghtPaul Jansen
Sep 17, 2011·QJM : Monthly Journal of the Association of Physicians·M AlbertonE J Mills
Nov 19, 2013·Journal of the American College of Cardiology·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Apr 29, 2014·American Heart Journal·Lingyun LuCynthia A Jackevicius
Jun 5, 2014·Circulation. Cardiovascular Quality and Outcomes·Lingyun LuCynthia A Jackevicius
Apr 26, 2015·Journal of Clinical Lipidology·Terry A JacobsonW Virgil Brown
Jul 28, 2016·Drugs·Stephan KrähenbühlArnold von Eckardstein
Nov 20, 2016·Cardiovascular Therapeutics·Samantha A HollingworthSusan E Tett
Mar 16, 2017·World Journal of Cardiology·Rahul ChaudharyAndrew Sumner
May 22, 2017·Journal of the American College of Cardiology·Gregory A RothChristopher Murray
Apr 17, 2018·Journal of Diabetes·Richard Ofori-AsensoDanny Liew
May 24, 2018·Cardiovascular Drugs and Therapy·Richard Ofori-AsensoDanny Liew
Jul 20, 2018·Drugs in Context·Marija Vavlukis, Ana Vavlukis
Dec 12, 2018·Atherosclerosis·Joseph E BlaisChung-Wah Siu
Apr 26, 2019·Journal of the American Heart Association·Alanna M ChamberlainRhonda M Cooper-DeHoff
Aug 17, 2019·Circulation. Cardiovascular Quality and Outcomes·Michael G NannaAnn Marie Navar
May 10, 2020·Journal of the American College of Cardiology·Deepak L BhattUNKNOWN ODYSSEY OUTCOMES Investigators
Jun 12, 2020·International Journal of Technology Assessment in Health Care·Sean Lybrand, Michael Wonder
Jul 4, 2020·Journal of the American College of Cardiology·Zhen ZhouMark R Nelson

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Cardiovascular Pharmacology and Therapeutics
Semira Abdi BeshirAmira S A Said
Current Vascular Pharmacology
Niki KatsikiAsterios Karagiannis
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
Juan Pedro-BotetExpert group from the Spanish Arteriosclerosis Society
© 2021 Meta ULC. All rights reserved